Are neutrophil to lymphocyte ratio and platelet to lymphocyte ratio clinically useful for the prediction of early pregnancy loss? by Oğlak, Süleyman Cemil & Aydın, Mustafa Fırat
524
ORIGINAL PAPER /  OBSTE TRICS
Ginekologia Polska
2020, vol. 91, no. 9, 524–527





Department of Obstetrics and Gynecology, Health Sciences University, Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey
phone: +905064021157
e-mail: sampson_21@hotmail.com
Are neutrophil to lymphocyte ratio and platelet  
to lymphocyte ratio clinically useful for the prediction 
of early pregnancy loss?
Süleyman Cemil Oğlak , Mustafa Fırat Aydın
Department of Obstetrics and Gynecology, Health Sciences University,  
Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey 
AbStrACt
Objectives: Red cell distribution width (RDW), mean platelet volume (MPV), plateletcrit (PCT), platelet distribution width 
(PDW), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have all been identified as systemic 
inflammatory markers. The aim of this study to investigate whether the use of systemic inflammatory markers can predict 
early pregnancy loss.
Material and methods: A total of 137 patients with early pregnancy loss was compared with 148 participants in the control 
group who had given birth at term. In the study group, CBC values were included in the study at the time of referral to the 
hospital for routine follow-up, while patients did not experience early pregnancy loss. In the control group, CBC values of 
the patient before the seventh week of pregnancy were included in the study. 
results: There was no significant difference between the two groups in terms of RDW, MPV, PCT and PDW values. The NLR 
and PLR values were significantly higher in the early pregnancy loss group than the control group (p < 0.05).
Conclusion: Our findings suggest that high NLR and PLR values are potent markers for the prediction of early pregnancy loss.   
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INtrODUCtİON
Early pregnancy loss is described as a nonviable, intrauter-
ine gestation with either an empty gestational sac or an em-
bryo/fetus without heartbeat within the first 12 6/7 weeks of 
gestation [1]. Approximately 10% of all clinically recognized 
pregnancies ending in an early loss and about 80% of all preg-
nancy losses occur in the first trimester [1]. Despite the high 
frequency of early pregnancy loss, its pathophysiology is still 
not fully understood [2]. Also, the natural history of early preg-
nancy loss, including temporal ordering of signs and symp-
toms in early pregnancy has not to be fully described [3]. The 
causes of early pregnancy losses have been reported in the 
literature as genetic causes, infectious causes, immunological 
causes, implantation abnormalities, anatomic abnormalities 
and endocrine disorders [4]. However, approximately 40% 
of early pregnancy losses are categorized as idiopathic [4]. 
Human pregnancy can be defined as the implantation 
of the semi-allogeneic fetus into the endometrium [5]. 
Complicated pregnancies such as hyperemesis gravidarum, 
preterm delivery, preeclampsia, gestational diabetes mel-
litus, intrahepatic cholestasis of pregnancy, frequently have 
an excessive inflammatory response that leads to adverse 
pregnancy outcomes [6]. The role of systemic inflammatory 
reactions in the pathogenesis of early pregnancy loss has 
been examined in several studies. In one study, it was stated 
that the women with euploid miscarriage had significantly 
higher levels of TNFα, IFNγ, IL-6 and IL-10 compared to nor-
mal pregnant controls [7]. However, the technical difficulties 
and high cost of evaluating inflammatory markers in the 
blood sample limited the use of these investigations in clini-
cal practice. Parameters such as red cell distribution width 
(RDW), platelet distribution width (PDW), mean platelet 
volume (MPV), plateletcrit (PCT), platelet-lymphocyte ratio 
(PLR) and neutrophil-lymphocyte ratio (NLR), which are 
readily available as systemic inflammation markers from 
complete blood count (CBC), are widely used in the diag-
nosis of many inflammatory diseases and prediction of the 
complicated pregnancies [8, 9]. The objective of this study 
to investigate whether the use of systemic inflammatory 
markers can predict early pregnancy loss.
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MAtErIAL AND MEtHODS
This retrospective study was conducted at the Obstetrics 
and Gynecology Department of the Gazi Yaşargil Training 
and Research Hospital, during the period from September 
2019 to December 2019. The study was approved by the 
same hospitals Ethics Committee.
The inclusion criteria of the study group were early preg-
nancy loss patients with ageing between 18–35 years old. The 
inclusion criteria of the control group were pregnant women 
with live birth ≥ 37 weeks and ageing between 18–35 years 
old. The two groups were matched for age and body mass 
index (BMI). The exclusion criteria for participation in the study 
were as follows: women with inadequate data, multiple gesta-
tion, molar pregnancy, a history of recurrent miscarriages or 
infertility, a known thrombophilia or any other medical condi-
tion needing chronic drug treatment, complicated pregnan-
cies (preeclampsia, gestational diabetes mellitus, intrahepatic 
cholestasis of pregnancy), any congenital uterine anomaly, 
large uterine fibroids and smoking during pregnancy. 
Age, gestational week, gravida, parity, body weight and 
height were obtained by examining the medical records of 
patients. The gestational week was determined by sono-
graphic measurement. BMI was calculated by dividing the 
body weight (in kilograms) by the square of the height (m2). 
In the study group, CBC values were included in the study 
at the time of referral to the hospital for routine follow-up, while 
patients did not experience early pregnancy loss. In the control 
group, CBC values of the patient before the seventh week of 
pregnancy were included in the study. The CBC values of the 
patients were measured with Mindray BC 6800, an automatic 
blood counting device using laser and impedance measure-
ment technique. Haemoglobin (Hb), white blood cell count 
(WBC), neutrophil count, lymphocyte count, platelet (PLT) 
count, RDW, PDW, MPV, PCT and CRP values were all derived 
from patient’ medical files. The NLR was calculated by dividing 
the neutrophil count by the lymphocyte count. The PLR was cal-
culated by dividing the platelet count by the lymphocyte count.
Statistical analysis
IBM SPSS 21.0 for Windows (SPSS Inc., Chicago, IL, USA) 
statistical package program was used for statistical evalua-
tion of our research data. Measured variables were presented 
as mean±standard deviation (std), and categorical variables 
were presented as numbers and percentages (%). Kolmogo-
rov-Smirnov test was used to determine whether the numerical 
data matched the normality distribution. Student’s t-test was 
used to compare the normally distributed data. Mann-Whitney 
U test was used to compare the non-normally distributed data. 
P < 0.05 was considered statistically significant.
rESULtS
A total of 137 patients with early pregnancy loss was com-
pared with 148 participants in the control group who had 
given birth at term. The demographic and clinical features 
of all patients are summarized in Table 1. The median age of 
the study group was 23, and the median age of the control 
group was 26. There was no significant difference between 
the two groups in terms of age, BMI, gravida and parity.  
The laboratory values of the groups are shown in Table 2. 
The haemoglobin, RDW, WBC, PLT count, PCT, MPV, and PDW 
table 2. Laboratory values of the groups
Variables Early pregnancy loss group (n = 137) Control group (n = 148) p value
Haemoglobin (g/dL)* 11.8 (8.6–13.1) 11.4 (9.3–12.7) > 0.05
RDW (%)** 11.6 ± 1.3 12.2 ± 1.5 > 0.05
WBC (/mm3 ×103)** 9.2 ± 2.6 8.4 ± 2.2 > 0.05
NEU (×103/uL)** 4.6 ± 1.4 3.4 ± 1.3 < 0.05
LYM (×103/uL)* 1.6 (0.4–3.4) 2.3 (0.9–4.2) < 0.05
Platelet (/mm3 ×103)* 264.1 (142.0–431.0) 257.8 (168.0–418.0) > 0.05
PCT (%)* 0.19 (0.12–0.35) 0.18 (0.13–0.33) > 0.05
MPV (fL)* 8.8 (6.8–10.9) 8.6 (6.7–10.7) > 0.05
PDW (%)* 15.8 (15.2–17.4) 15.2 (12.1–16.7) > 0.05
NLR* 3.5 (1.3–7.1) 1.9 (1.1–4.2) < 0.05
PLR* 150.7 (71.6–339.2) 84.1 (46.4–204.3) < 0.05
* — median (minimum-maksimum); ** — mean ± standart deviation
table 1. Demographic and clinical features of the groups
Variables Early pregnancy loss group (n = 137)
Control group
(n = 148) p value
Age (years)* 23 (18–35) 26 (19–35) > 0.05
BMI (kg/m2)** 23.12 ± 3.66 23.78 ± 3.82 > 0.05
Gravida* 3 (1–5) 4 (1–6) > 0.05
Parity* 1 (0–4) 1 (0–5) > 0.05
* — median (minimum-maksimum); ** — mean ± standart deviation
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values were not significantly different between the early 
pregnancy loss and control groups. The neutrophil count 
was significantly higher (p < 0.05) and the lymphocyte count 
was significantly lower (p < 0.05) in the early pregnancy 
loss group than the control group. The NLR and PLR values 
were significantly higher in the early pregnancy loss group 
than the control group (p < 0.05).
DISCUSSION
In this retrospective study, we compared first-trimester 
systemic inflammatory markers of pregnant women with 
a live birth at ≥ 37 weeks with those pregnancies ended with 
an early loss. Our findings indicate that early pregnancy loss 
has an association with systemic inflammation.
During pregnancy, there is an increase in systemic in-
flammation [10]. Regulated inflammation is essential in 
every stage of pregnancy [11]. Physiologic regulation of 
immune response prevents the rejection of semi-allogeneic 
fetus, and this regulation is mainly through changes in cy-
tokine levels [10]. Deregulation of this mechanism can cause 
adverse pregnancy outcomes such as spontaneous or recur-
rent abortion, preeclampsia, preterm labour, and intrauter-
ine growth restriction [10]. 
In several studies, it was reported that the cytokine levels 
are different in women with recurrent miscarriages. In the 
study of O’Hern Perfetto et al. [12], it was suggested that 
the lower levels of IL-22 in the uterine decidua in patients 
with unexplained recurrent pregnancy loss. However, there 
are conflicting results in the literature about the status of 
the systemic inflammatory response in spontaneous mis-
carriage. In a study conducted by Sacerdoti et al. [13], de-
crease in local vascular endothelial growth factor (VEGF) 
may contribute to the early pregnancy loss. In contrast, in 
the study of Ku et al. [14], it was reported that there was no 
correlation between circulating IL-6 levels with spontane-
ous miscarriage.  
Inflammatory markers, which are associated with early 
pregnancy loss in various studies, are not available in all 
centers due to technical difficulties and high costs. The 
diagnostic value of systemic inflammatory markers such as 
NLR, PLR, PDW, MPV, PCT, RDW in many diseases such as pre-
eclampsia, coronary artery disease, autoimmune diseases, 
inflammatory diseases has already been shown in several 
studies [15, 16]. However, there are few studies and insuf-
ficient data in the literature on the relationship between 
these markers and early pregnancy loss. In this study, we 
planned our study to evaluate whether these markers, which 
we can quickly obtain with the complete blood count, have 
changed in patients before early pregnancy loss.  
High RDW values are thought to reflect increased inflam-
mation and oxidative stress [17]. In addition to their central 
role in hemostasis, studies have shown that platelets are po-
tent immune modulators and effectors [18]. PDW, MPV and 
PCT are regarded to be markers of platelet activation [19]. 
It was shown that PLT count, PCT and RDW was signifi-
cantly higher in patients with recurrent pregnancy loss 
than in controls [20]. However, in our study, there was no 
significant difference between the early pregnancy loss and 
control groups in terms of RDW, PLT count, PCT and MPV 
values. These results suggest that platelet activation may not 
have a significant role in the pathogenesis of inflammation 
in spontaneous early pregnancy loss. These results can also 
be explained by the exclusion of patients with recurrent 
abortion or chronic diseases into the study. Studies with 
a large number of patients needed in this regard.  
In many systemic inflammatory diseases and malignan-
cies, the physiological response of the immune system is to 
increase the neutrophil count and decrease in lymphocyte 
count, and this has lead to the widespread use of NLR and 
PLR values in the diagnosis and evaluating the prognosis of 
inflammatory diseases [21]. Also, in several studies, it was 
reported that high NLR values during the first trimester were 
powerful predictors of subsequent complicated pregnan-
cies such as preeclampsia, gestational diabetes and intrahe-
patic cholestasis of pregnancy [22–24]. However, there are 
few studies investigating the association between NLR and 
PLR values and early pregnancy loss. In a study by Christofo-
raki et al., it was found that NLR does not differ significantly 
between pregnant women with live birth and those whose 
pregnancy ended in miscarriage [25]. In contrast, in the 
study of Bas et al., NLR and PLR values evaluated at the sixth 
gestational week can be used for the risk assessment of 
spontaneous abortion. In our study, when the groups were 
compared, NLR and PLR values were significantly higher 
in the early pregnancy loss group than the control group.  
The strength of the study is that there are few studies 
in the literature about predicting early pregnancy loss with 
systemic inflammatory markers. Excluding women with all 
possible confounding factors that can cause early pregnancy 
loss, such as advanced maternal age, multiple pregnancies, 
recurrent miscarriage, chronic diseases is another strength 
of the study.
There are some limitations to this study. This study has 
been designed retrospectively and has the potential to 
contain limitations of such studies. Another limitation is 
the absence of pro-inflammatory cytokines such as TNF-α, 
VEGF, IL-6, which have been previously identified with early 
pregnancy loss. A study by correlating the results of systemic 
inflammatory markers with these cytokines may provide 
more insight into the prediction of early pregnancy loss.  
CONCLUSİON
The results of this study suggest that NLR and PLR are 
potent markers in the prediction of early pregnancy loss.
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